Abstract:Peroxisome proliferator‐activated receptor alpha (PPAR‐α) is a major transcription factor that governs the expression of fatty acid oxidation (FAO) and anti‐inflammatory genes during fasting. Acyl‐CoA thioesterase 1 (ACOT1) hydrolyzes acyl‐CoAs to long‐chain free fatty acids and Coenzyme A during fasting. ACOT1 activity seemingly removes acyl‐CoA substrate for mitochondrial FAO and produces long‐chain free fatty acids that could serve as ligands to activate PPAR‐α. The objective of this research was to identify the role of ACOT1 in hepatic fasting lipid metabolism. To test our objectives, we injected C57Bl/6 mice with an adenovirus harboring shRNA targeted to ACOT1 or a scrambled control. Week‐long liver specific knockdown of ACOT1 increased FAO in vivo measured by serum β‐hydroxybutyrate and reduced liver triglyceride. These data correlated to results from in vitro fatty acid tracer studies in which ACOT1 knockdown increased FAO and triglyceride turnover. Despite increased FAO, ACOT1 knockdown reduced the expression of PPAR‐α target genes involved in FAO. In addition, ACOT1 knockdown led to increased expression of inflammatory and oxidative stress genes, due to reduced PPAR‐α dependent anti‐inflammatory signaling. Moreover, in vitro experiments exhibited increased PPAR‐α reporter activity in COS7 cells overexpressing ACOT1. The ability of ACOT1 to increase PPAR‐α activity was dependent on its catalytic activity, suggesting that ACOT1 produces fatty acids that serve as ligands for PPAR‐α. To confirm this theory, mice were supplemented with a synthetic PPAR‐α ligand, Wy‐14643, which rescued the expression of PPAR‐α target genes and mitigated the inflammation and oxidative stress observed in response to ACOT1 knockdown. Importantly, ACOT1 exhibits nuclear localization during prolonged fasting or under β‐adrenergic stimulation, suggesting a local pool of free fatty acids activate PPAR‐α.Together these studies suggest that ACOT1 coordinates the rate of fatty acid oxidation while simultaneously producing fatty acids that activate PPAR‐α, potentially in the nucleus, to protect the liver from inflammation and oxidative stress. Support or Funding Information NIH/NIDDK T32 Training grant, Minnesota Obesity Training Program Predoctoral Fellowship (DK083250), awarded to Mallory Franklin.

Enhanced Acyl-Coa:Cholesterol Acyltransferase Activity Increases Cholesterol Levels on the Lipid Droplet Surface and Impairs Adipocyte Function

Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice

Acetyl-coenzyme A Acyltransferase 2 Promote the Differentiation of Sheep Precursor Adipocytes into Adipocytes.

Adipophilin Accumlating Cellular Cholesterylester by Acyl-Coenzyme A:Cholesterol Acyltransferase in THP-1 Macrophages

Adipocyte Modulation of High-Density Lipoprotein Cholesterol

ACAT2 Is a Novel Negative Regulator of Pig Intramuscular Preadipocytes Differentiation

Abstract 19596: Endothelial Acyl-CoA Synthetase 1 is not Required for Saturated Fatty Acid- Mediated Inflammatory and Apoptotic Effects

Acyl‐CoA Thioesterase 1 regulates hepatic lipid metabolism and PPAR‐α signaling

Cholesterol and Fatty Acids Regulate Cysteine Ubiquitylation of Acat2 Through Competitive Oxidation

Adipose tissue regulates hepatic cholesterol metabolism via adiponectin

ACAT1 Regulates the Dynamics of Free Cholesterols in Plasma Membrane Which Leads to the APP-α-processing Alteration.

Human Acyl-coenzyme A:cholesterol Aacyltransferase(ACAT)

Myeloid Acat1/Soat1 KO Attenuates Pro-Inflammatory Responses in Macrophages and Protects Against Atherosclerosis in a Model of Advanced Lesions

Enhancement of Human ACAT1 Gene Expression to Promote the Macrophage-Derived Foam Cell Formation by Dexamethasone

The ACAT2 Expression of Human Leukocytes is Responsible for the Excretion of Lipoproteins Containing Cholesteryl/steryl Esters.

Posttranscriptional Control of the Expression and Function of Diacylglycerol Acyltransferase-1 in Mouse Adipocytes

Abstract 317: Adipose Tissue Phosphatidylcholine Remodeling Modulates Insulin Signaling

Cholesterol Imbalance In Adipocytes: A Possible Mechanism Of Adipocytes Dysfunction In Obesity

Mechanisms of Increased Activity of Acyl Coenzyme A:cholesteryl Acyltransferase1 in Macrophages by Ac-LDL

Adipocyte Ablation of Long‐Chain Acyl‐CoA Synthetase‐4 (ACSL4) Protects Against Diet‐Induced Obesity

Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption